These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6323199)

  • 1. Monoclonal antibodies against diphtheria toxin fragment A. Characterization and introduction into living cells.
    Yoshimori T; Yamada M; Sugawa H; Mekada E; Uchida T; Okada Y
    Exp Cell Res; 1984 Apr; 151(2):344-53. PubMed ID: 6323199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diphtheria toxin mutant CRM197 possesses weak EF2-ADP-ribosyl activity that potentiates its anti-tumorigenic activity.
    Kageyama T; Ohishi M; Miyamoto S; Mizushima H; Iwamoto R; Mekada E
    J Biochem; 2007 Jul; 142(1):95-104. PubMed ID: 17525101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody analysis of diphtheria toxin--II. Inhibition of ADP-ribosyl-transferase activity.
    Zucker DR; Murphy JR; Pappenheimer AM
    Mol Immunol; 1984 Sep; 21(9):795-800. PubMed ID: 6207426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular stability of diphtheria toxin fragment A in the presence and absence of anti-fragment A antibody.
    Yamaizumi M; Uchida T; Takamatsu K; Okada Y
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):461-5. PubMed ID: 6952197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a diphtheria toxin A fragment-C180 peptide fusion protein which elicits a neutralizing antibody response against diphtheria toxin and pertussis toxin.
    Barbieri JT; Armellini D; Molkentin J; Rappuoli R
    Infect Immun; 1992 Dec; 60(12):5071-7. PubMed ID: 1452339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine monoclonal antibodies neutralizing the cytotoxic activity of diphtheria toxin.
    Usuwanthim K; Pootong A; Chaisri U; Tongtawe P; Tapchaisri P; Chongsa-Nguan M; Chaicumpa W
    Asian Pac J Allergy Immunol; 2008 Mar; 26(1):47-55. PubMed ID: 18595529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding properties of diphtheria toxin to cells are altered by mutation in the fragment A domain.
    Mekada E; Uchida T
    J Biol Chem; 1985 Oct; 260(22):12148-53. PubMed ID: 4044590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diphtheria toxin NAD affinity and ADP ribosyltransferase activity are reduced at tryptophan 153 substitutions for alanine or phenylalanine.
    Zdanovskaia MV; Zdanovsky AG; Yankovsky NK
    Res Microbiol; 2000 Sep; 151(7):557-62. PubMed ID: 11037133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of diphtheria toxin in Streptococcus mutans and induction of toxin-neutralizing antisera.
    Lee CW; Halperin SA; Morris A; Lee SF
    Can J Microbiol; 2005 Oct; 51(10):841-6. PubMed ID: 16333343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies against Vero cells that protect against diphtheria toxin.
    Rönnberg BJ; Lidgerding BC; Middlebrook JL
    Toxicon; 1989; 27(10):1095-104. PubMed ID: 2815107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the endogenous ADP-ribosylation of wild-type and mutant elongation factor 2 in eukaryotic cells.
    Fendrick JL; Iglewski WJ; Moehring JM; Moehring TJ
    Eur J Biochem; 1992 Apr; 205(1):25-31. PubMed ID: 1313365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell.
    Yamaizumi M; Mekada E; Uchida T; Okada Y
    Cell; 1978 Sep; 15(1):245-50. PubMed ID: 699044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low pH-induced release of diphtheria toxin A-fragment in Vero cells. Biochemical evidence for transfer to the cytosol.
    Moskaug JO; Sandvig K; Olsnes S
    J Biol Chem; 1988 Feb; 263(5):2518-25. PubMed ID: 3339019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of guinea-pig immune sera elicited by a synthetic diphtheria toxin oligopeptide.
    Boquet P; Alouf JE; Duflot E; Siffert O; Rivaille P
    Mol Immunol; 1982 Dec; 19(12):1541-9. PubMed ID: 7162517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of diphtheria toxin fragment A and of elongation factor 2 with cibacron blue.
    Rambelli F; Brigotti M; Sperti S; Montanaro L
    Biosci Rep; 1987 Sep; 7(9):737-43. PubMed ID: 3427221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody analysis of diphtheria toxin--I. Localization of epitopes and neutralization of cytotoxicity.
    Zucker DR; Murphy JR
    Mol Immunol; 1984 Sep; 21(9):785-93. PubMed ID: 6207425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antitoxic properties of monoclonal antibodies against diphtheria toxin].
    Zaĭtsev EM; Sviridov VV; Titova NG; Lebedev VS; Garipova MI
    Mol Gen Mikrobiol Virusol; 1985 Feb; (2):37-41. PubMed ID: 2432418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and immunogenicity of a recombinant diphtheria toxin fragment A in Streptococcus gordonii.
    Lee CW; Lee SF; Halperin SA
    Appl Environ Microbiol; 2004 Aug; 70(8):4569-74. PubMed ID: 15294787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstitution of active diphtheria toxin based on a hexahistidine tagged version of the B-fragment produced to high yields in bacteria.
    Spilsberg B; Sandvig K; Wälchli S
    Toxicon; 2005 Dec; 46(8):900-6. PubMed ID: 16260019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the role of a nucleoside-phosphate-binding site of diphtheria toxin in the binding of toxin to Vero cells or liposomes.
    Boquet P; Duflot E
    Eur J Biochem; 1981 Dec; 121(1):93-8. PubMed ID: 6895727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.